Phase 2 Study of Mitoxantrone, Etoposide, and Cytarabine (MEC) Plus Lenalidomide for the Treatment of Adult Patients With Relapsed or Refractory Acute Myeloid Leukemia
Phase of Trial: Phase II
Latest Information Update: 25 May 2018
At a glance
- Drugs Lenalidomide (Primary) ; Cytarabine; Etoposide; Mitoxantrone
- Indications Acute biphenotypic leukaemia; Acute myeloid leukaemia
- Focus Therapeutic Use
- 27 Oct 2017 Status changed from not yet recruiting to recruiting.
- 21 Jul 2017 Planned initiation date changed from 30 May 2017 to 31 Aug 2017.
- 10 May 2017 Planned initiation date changed from 30 Apr 2017 to 30 May 2017.